[1]
“Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy”, JOC, vol. 24, no. 6s, pp. 232–242, Sep. 2025, doi: 10.64149/J.Carcinog.24.6s.232-242.